CKF Tide Tables

HGH (Somatropin)

Quick Facts

PropertyValue
CategoryGrowth Hormone / Performance Hormone
Risk LevelModerate/High
AdministrationSubcutaneous Injection
Typical FrequencyDaily
Estimated Half-LifeShort Plasma Half-Life / Longer IGF-1 Effects
Primary Research InterestRecovery / Fat Loss / Performance / Body Composition
Important Disclaimer

This material is provided strictly for educational and informational purposes related to peptide and hormone research. Human Growth Hormone (HGH) is a biologically active hormone capable of significantly altering IGF-1 signaling, metabolism, insulin sensitivity, tissue growth pathways, and recovery mechanisms. Information presented here should not be interpreted as medical advice, treatment recommendations, or encouragement of unsupervised use.

1. Reconstitution Guide

* Special Measurement Note: This compound is measured in International Units (IU) rather than milligrams (mg). For more information about IU measurements and why some compounds are measured differently, please see the CKF Tide Tables “Weights & Measures” information page.

  • Vial Size: 36 IU
  • Dilutant Type: BAC Water
  • Amount of Dilutant Added: 3 mL
  • Final Concentration: 12.00 IU/mL

At this concentration:
• 2 IU = 0.167 mL (16.7 units)
• 4 IU = 0.333 mL (33.3 units)
• 8 IU = 0.667 mL (66.7 units)

2. Route of Administration

Human Growth Hormone is most commonly administered as a subcutaneous injectable hormone.

  • Primary Route: SubQ Injection
  • Preferred Timing: Morning fasted or split between morning fasted and bedtime
  • Administration Notes: Often researched in conjunction with training, recovery, fat-loss, or performance-focused protocols

3. Typical Research Protocols

  • Product Strength: 12.00 IU/mL
  • Typical Delivered Amount: 2–4 IU/day for fat-loss or body recomposition research. 4–8 IU/day for bodybuilding and performance-oriented research.
  • Frequency: Daily
  • Cycle Length: Continuous year-round cycle
  • Special Notes: Human Growth Hormone typically produces gradual effects, with recovery, skin quality, and fat-loss changes often becoming more noticeable over weeks to months rather than days. Early water retention is very common and can temporarily mask true body-composition changes. Higher doses increase the importance of monitoring blood glucose and insulin sensitivity. Many users combine HGH with training, high-protein nutrition, or other performance compounds, though stacking can significantly increase complexity and risk.

4. Summary

Human Growth Hormone (HGH) is a naturally occurring anabolic hormone researched for its potential effects on recovery, tissue repair, body composition, fat metabolism, performance enhancement, and IGF-1 signaling.

Research interest in HGH commonly centers around recovery enhancement, lean mass support, fat reduction, skin quality, connective tissue repair, and performance-oriented applications.

5. Mechanism of Action

HGH functions by stimulating growth hormone receptors and increasing downstream IGF-1 production, influencing metabolism, tissue repair, recovery, and anabolic signaling pathways.

  • IGF-1 signaling enhancement
  • Tissue repair support
  • Fat metabolism modulation
  • Recovery signaling
  • Potential connective tissue support
  • Anabolic pathway activation

The hormone is frequently researched in both anti-aging and performance-oriented contexts.

6. Potential Benefits

  • Potential fat-loss support
  • Improved recovery signaling
  • Possible lean mass retention support
  • Enhanced skin quality signaling
  • Potential connective tissue recovery
  • Improved sleep and recovery quality in some users

7. Potential Risks / Side Effects

Moderate/High

  • Water retention
  • Joint discomfort
  • Numbness or tingling
  • Insulin resistance
  • Blood glucose dysregulation
  • Potential edema
  • Possible organ growth concerns at excessive doses

8. Half-Life

Human Growth Hormone has a relatively short circulating plasma half-life.

However, downstream IGF-1 signaling effects persist significantly longer and contribute to its prolonged physiological impact.

9. Storage Information

  • Store refrigerated before and after reconstitution
  • Protect from direct light exposure
  • Avoid excessive agitation during reconstitution
  • Maintain sterile handling practices during preparation

10. Contraindications / Warnings

  • Active cancer or tumor growth concerns
  • Uncontrolled diabetes
  • Severe cardiovascular disease
  • Pregnancy or breastfeeding
  • Known hypersensitivity to HGH compounds

11. Research References

  • PubMed
  • NIH Publications
  • Endocrinology literature
  • Peer-reviewed sports medicine and metabolism journals